|
MYBL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.84460000000653E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.223370E-04 |
| Normal-vs-Stage2 |
3.92100000000672E-05 |
| Normal-vs-Stage3 |
5.90649999999693E-05 |
| Normal-vs-Stage4 |
6.39029999999208E-05 |
| Stage1-vs-Stage2 |
1.671250E-01 |
| Stage1-vs-Stage3 |
3.456200E-01 |
| Stage1-vs-Stage4 |
4.298400E-01 |
| Stage2-vs-Stage3 |
6.718200E-01 |
| Stage2-vs-Stage4 |
7.024000E-01 |
| Stage3-vs-Stage4 |
9.918200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.047520E-04 |
| Normal-vs-AfricanAmerican |
5.71999999999795E-05 |
| Normal-vs-Asian |
6.09429999999245E-05 |
| Caucasian-vs-AfricanAmerican |
3.646400E-01 |
| Caucasian-vs-Asian |
4.381400E-01 |
| AfricanAmerican-vs-Asian |
9.302000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.47080000000044E-05 |
| Normal-vs-Female |
9.9077000000003E-05 |
| Male-vs-Female |
3.529400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.581990E-04 |
| Normal-vs-Age(41-60Yrs) |
2.36939999999075E-05 |
| Normal-vs-Age(61-80Yrs) |
1.805050E-04 |
| Normal-vs-Age(81-100Yrs) |
3.854100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.005900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.410000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.842250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.711970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.019000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.252200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.441200E-01 |
| Classical-VS-Follicular |
1.099600E-01 |
| Classical-VS-Other |
2.110000E-02 |
| Classical-VS-Normal |
1.378530E-04 |
| Tall-VS-Follicular |
3.011000E-01 |
| Tall-VS-Other |
5.725900E-02 |
| Tall-VS-Normal |
5.799900E-04 |
| Follicular-VS-Other |
1.489840E-01 |
| Follicular-VS-Normal |
4.04440000000283E-05 |
| Other-VS-Normal |
4.14240000001787E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.59609999999378E-05 |
| Normal-vs-N1 |
2.14039999999471E-05 |
| N0-vs-N1 |
2.985600E-01 |
|
|
